Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Kyriakopoulos (Ioannina, Greece), C. Chronis (Ioannina, Greece), A. Tatsioni (Ioannina, Greece), E. Papapetrou (Ioannina, Greece), A. Gogali (Ioannina, Greece), K. Vaggeli (Ioannina, Greece), C. Katsanos (Ioannina, Greece), C. Tsaousi (Ioannina, Greece), C. Tsalepi (Ioannina, Greece), A. Charisis (Ioannina, Greece), M. Kosta (Ioannina, Greece), A. Spanou (Ioannina, Greece), K. Kostikas (Ioannina, Greece), A. Konstantinidis (Ioannina, Greece). Hypercoagulability in patients with stable COPD assessed by coagulation factor levels. 3578

Member's Comments

No comment yet.

Related content which might interest you: PP220 – Hypercoagulability in patients with stable COPD assessed by coagulation factor levels Source: ERS Lung Science Conference 2021 Year: 2021 The importance of high plasma levels of factor VIIIc in the severity of pulmonary thromboembolism Source: Eur Respir J 2001; 18: Suppl. 33, 252s Year: 2001 Serum levels of proangiogenic factors before and after the correction of severe hypoxemia in COPD patients Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 Serum levels of vascular endothelial growth factor (VEGF) are elevated in patients with acute exacerbated COPD Source: Eur Respir J 2005; 26: Suppl. 49, 350s Year: 2005 Elevated factor FVIII:C levels in patients with pulmonary hypertension: a marked of endothelial dysfunction? Source: Eur Respir J 2003; 22: Suppl. 45, 584s Year: 2003 Plasma high fibrinogen and low plasminogen levels predict poor prognosis in patients with inoperable chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Prothrombotic alterations to blood coagulation and fibrinolysis in clinically stable asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 C-reactive protein levels and clinically important predictive outcomes in stable COPD patients Source: Eur Respir J 2006; 27: 902-907 Year: 2006 Relationship between circulating thrombomodulin levels and latent progression of atherosclerosis in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Effect of acute exacerbations on circulating thrombotic and fibrinolytic markers in COPD patients Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 652s Year: 2006 Thromboprophylaxis and the relationship between C-reactive protein and plasma fibrinogen in patients with acute exacerbations of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007 Serum leptin and tumor necrosis factor – alpha levels and maximal exercise performance in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Respiratory muscles in disease Year: 2008 Elevated Von Willebrand Factor expression in the activated pulmonary endothelium of chronic thromboembolic pulmonary hypertension patients enhances platelet adhesion. Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Factors influencing induced sputum cytokines and VEGF in a population of stable COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 550s Year: 2006 Circulating vascular endothelial growth factor and osteoporosis in patients with COPD Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009 Factors affecting C-reactive protein levels in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Inflammatory mediators CRP, fibrinogen and leukocyte in stable COPD patients Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I Year: 2007 VEGF serum levels in COPD patients without pulmonary hypertension – a case control study Source: International Congress 2018 – Biomarkers of COPD Year: 2018